Clinical data simplified.

[1]  Robert M Califf,et al.  Clinical research sites--the underappreciated component of the clinical research system. , 2009, JAMA.

[2]  David M Dilts,et al.  Invisible barriers to clinical trials: the impact of structural, infrastructural, and procedural barriers to opening oncology clinical trials. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  Richard L Schilsky,et al.  Processes to activate phase III clinical trials in a Cooperative Oncology Group: the Case of Cancer and Leukemia Group B. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  R. Califf Simple principles of clinical trials remain powerful. , 2005, JAMA.

[5]  D. Stryer,et al.  Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. , 2003, JAMA.

[6]  D. Brat,et al.  Extraventricular Neurocytomas: Pathologic Features and Clinical Outcome , 2001, The American journal of surgical pathology.

[7]  P. Burger,et al.  Extraventricular neoplasms with neurocytoma features. A clinicopathological study of 11 cases. , 1997, The American journal of surgical pathology.

[8]  D. P. Thomas Sailors, scurvy and science , 1997, Journal of the Royal Society of Medicine.

[9]  R. Peto,et al.  Large‐Scale Randomized Evidence: Large, Simple Trials and Overviews of Trials , 1993, Journal of clinical epidemiology.

[10]  Frans Van de Werf,et al.  An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. , 1993, The New England journal of medicine.

[11]  P. Easterbrook,et al.  Publication bias in clinical research , 1991, The Lancet.

[12]  K. Dickersin,et al.  Publication bias and clinical trials. , 1987, Controlled clinical trials.

[13]  Gruppo Italiano per lo Studio della Soprawivenza nell'Inf Miocardico.,et al.  EFFECTIVENESS OF INTRAVENOUS THROMBOLYTIC TREATMENT IN ACUTE MYOCARDIAL INFARCTION , 1986, The Lancet.